IRADIMED CORP — Director's Dealing 2019

Oct 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2019-10-17

Reporting Person: JOHNSON BRENT (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-17	Common Stock	A	2000	$0.93	Acquired	3368	Direct
2019-10-17	Common Stock	S	2000	$22.6	Disposed	1368	Direct
2019-10-18	Common Stock	A	2000	$0.93	Acquired	3368	Direct
2019-10-18	Common Stock	S	2000	$22.9	Disposed	1368	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-17	Stock Option (Right to Buy)	$0.93	M	2000	Disposed	2021-12-27	Common Stock (2000)	Direct
2019-10-18	Stock Option (Right to Buy)	$0.93	M	2000	Disposed	2021-12-27	Common Stock (2000)	Direct

Footnotes

F1: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2019.

F2: This option, representing a right to purchase a total of 432,775 shares, was granted on 12/31/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.